Posted on 5월 8, 20255/8/25
Pitch Perfect: Strategic Guidance for Biotech Phase II Asset Acquisition
Posted on 4월 22, 20254/22/25
Maximize Access
Posted on 4월 22, 20254/22/25
Maximize Price
Posted on 4월 22, 20254/22/25
Maximize Coverage
Posted on 11월 4, 202411/4/24
Coding and Reimbursement Assessment for Potential Acquisition
Posted on 11월 4, 202411/4/24
Radiopharmaceutical Indication Prioritization
Posted on 11월 4, 202411/4/24
Pricing Strategy for Inpatient Therapy
Posted on 11월 4, 202411/4/24
Cardiovascular Disease State Assessment with EVERSANA Management Consulting
Posted on 11월 4, 202411/4/24
Integrated Brand Planning with EVERSANA MANAGEMENT CONSULTING
Posted on 11월 4, 202411/4/24